S&P 500   5,075.68 (-0.05%)
DOW   38,933.91 (-0.10%)
QQQ   435.68 (-0.44%)
AAPL   180.56 (-1.13%)
MSFT   407.14 (-0.08%)
META   486.71 (-0.07%)
GOOGL   135.94 (-2.12%)
AMZN   173.79 (+0.14%)
TSLA   202.84 (+1.56%)
NVDA   784.31 (-0.34%)
NIO   5.48 (-5.19%)
AMD   176.07 (-1.08%)
BABA   75.02 (-3.42%)
T   17.01 (+1.07%)
F   12.32 (+2.67%)
MU   89.65 (-2.40%)
CGC   3.43 (-2.83%)
GE   155.22 (+0.80%)
DIS   110.81 (+1.27%)
AMC   4.90 (+1.87%)
PFE   27.15 (+0.97%)
PYPL   60.39 (+0.38%)
XOM   104.29 (+0.25%)
S&P 500   5,075.68 (-0.05%)
DOW   38,933.91 (-0.10%)
QQQ   435.68 (-0.44%)
AAPL   180.56 (-1.13%)
MSFT   407.14 (-0.08%)
META   486.71 (-0.07%)
GOOGL   135.94 (-2.12%)
AMZN   173.79 (+0.14%)
TSLA   202.84 (+1.56%)
NVDA   784.31 (-0.34%)
NIO   5.48 (-5.19%)
AMD   176.07 (-1.08%)
BABA   75.02 (-3.42%)
T   17.01 (+1.07%)
F   12.32 (+2.67%)
MU   89.65 (-2.40%)
CGC   3.43 (-2.83%)
GE   155.22 (+0.80%)
DIS   110.81 (+1.27%)
AMC   4.90 (+1.87%)
PFE   27.15 (+0.97%)
PYPL   60.39 (+0.38%)
XOM   104.29 (+0.25%)
S&P 500   5,075.68 (-0.05%)
DOW   38,933.91 (-0.10%)
QQQ   435.68 (-0.44%)
AAPL   180.56 (-1.13%)
MSFT   407.14 (-0.08%)
META   486.71 (-0.07%)
GOOGL   135.94 (-2.12%)
AMZN   173.79 (+0.14%)
TSLA   202.84 (+1.56%)
NVDA   784.31 (-0.34%)
NIO   5.48 (-5.19%)
AMD   176.07 (-1.08%)
BABA   75.02 (-3.42%)
T   17.01 (+1.07%)
F   12.32 (+2.67%)
MU   89.65 (-2.40%)
CGC   3.43 (-2.83%)
GE   155.22 (+0.80%)
DIS   110.81 (+1.27%)
AMC   4.90 (+1.87%)
PFE   27.15 (+0.97%)
PYPL   60.39 (+0.38%)
XOM   104.29 (+0.25%)
S&P 500   5,075.68 (-0.05%)
DOW   38,933.91 (-0.10%)
QQQ   435.68 (-0.44%)
AAPL   180.56 (-1.13%)
MSFT   407.14 (-0.08%)
META   486.71 (-0.07%)
GOOGL   135.94 (-2.12%)
AMZN   173.79 (+0.14%)
TSLA   202.84 (+1.56%)
NVDA   784.31 (-0.34%)
NIO   5.48 (-5.19%)
AMD   176.07 (-1.08%)
BABA   75.02 (-3.42%)
T   17.01 (+1.07%)
F   12.32 (+2.67%)
MU   89.65 (-2.40%)
CGC   3.43 (-2.83%)
GE   155.22 (+0.80%)
DIS   110.81 (+1.27%)
AMC   4.90 (+1.87%)
PFE   27.15 (+0.97%)
PYPL   60.39 (+0.38%)
XOM   104.29 (+0.25%)

Bristol-Myers Squibb (BMY) SEC Filings & 10K Form

$50.70
+0.19 (+0.38%)
(As of 01:22 PM ET)

Recent Bristol-Myers Squibb SEC Filings

DateFilerForm TypeView
02/23/2024
5:03 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/16/2024
3:34 PM
Bristol-Myers Squibb (Filer)
Form 424B5
02/16/2024
10:36 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/14/2024
8:07 PM
Bristol-Myers Squibb (Subject)
Form FWP
02/13/2024
10:54 AM
Bristol-Myers Squibb (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2024
7:00 AM
Bristol-Myers Squibb (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/12/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/05/2024
6:29 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:31 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:33 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:10 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:13 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:15 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:17 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:21 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:24 PM
Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:26 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:27 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:46 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
7:13 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T
01/08/2024
9:29 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:48 PM
Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2024
4:38 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:39 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:41 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:44 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:31 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:33 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:36 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
3:22 PM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-C
12/22/2023
3:36 PM
Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
Form DFAN14A
12/22/2023
3:21 PM
Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
Form DFAN14A
12/20/2023
5:08 PM
Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
5:06 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:21 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:22 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:23 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:32 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:38 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
6:01 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:30 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
3:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K/A
10/30/2023
4:26 PM
Bristol-Myers Squibb (Subject)
Form FWP
10/30/2023
7:05 AM
Bristol-Myers Squibb (Filer)
Form 424B3
10/26/2023
11:33 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
6:44 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
6:13 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
5:48 AM
Bristol-Myers Squibb (Filed by)
Mirati Therapeutics, Inc. (Subject)
Form DFAN14A
10/04/2023
8:01 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
8:04 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:29 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:31 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:33 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:34 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:36 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:38 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:26 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
4:28 PM
Bristol-Myers Squibb (Issuer)
Powell Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
1:17 PM
Bristol-Myers Squibb (Subject)
Powell Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
6:10 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
4:24 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
2:54 PM
Bristol-Myers Squibb (Subject)
Plenge Robert M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/27/2023
6:50 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
8:34 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/05/2023
4:31 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:33 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:34 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:35 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:37 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:23 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:26 PM
Bristol-Myers Squibb (Issuer)
Weese Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:28 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
4:30 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
6:39 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:51 PM
Bristol-Myers Squibb (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
3:48 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:35 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2023
6:36 PM
Bristol-Myers Squibb (Issuer)
Greenlees Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
6:37 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
12:45 PM
Bristol-Myers Squibb (Subject)
VESSEY RUPERT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/27/2023
6:45 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2023
3:38 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
04/26/2023
3:35 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2023
4:12 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
04/04/2023
8:01 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:38 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:38 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:39 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:39 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:40 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:40 PM
Bristol-Myers Squibb (Issuer)
Mily Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:37 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
7:38 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2023
3:40 PM
Bristol-Myers Squibb (Filer)
Form DEF 14A
03/23/2023
3:41 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
03/23/2023
3:43 PM
Bristol-Myers Squibb (Filer)
Form ARS
03/14/2023
7:34 PM
Bristol-Myers Squibb (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2023
7:40 PM
Bristol-Myers Squibb (Issuer)
Mily Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:BMY) was last updated on 2/28/2024 by MarketBeat.com Staff